Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model.
Ontology highlight
ABSTRACT: Periostin and mesothelin have each been suggested to be predictors of poor survival for patients with intrahepatic cholangiocarcinoma, although the clinical prognostic value of both of these biomarkers remains uncertain. The aim of the current study was to investigate these biomarkers for their potential to act as tumor progression factors when assessed in orthotopic tumor and three-dimensional culture models of rat cholangiocarcinoma progression. Using our orthotopic model, we demonstrated a strong positive correlation between tumor and serum periostin and mesothelin and increasing liver tumor mass and associated peritoneal metastases that also reflected differences in cholangiocarcinoma cell aggressiveness and malignant grade. Periostin immunostaining was most prominent in the desmoplast
SUBMITTER: Manzanares MA
PROVIDER: S-EPMC5796331 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA